Tanzania Strengthens Cross-Border Disease Control
This urgency prompted the Tanzania Ministry of Health, with support from the East, Central, and Southern Africa Health Community (ECSA-HC), WHO, and technical support from Africa CDC, the International Organization for Migration, and other partners, to convene a cross-border meeting between Tanzania and Burundi. Held from February 10-12, the meeting focused on revitalizing Public Health Emergency Contingency Plans (PHECPs), enhancing disease surveillance, and strengthening joint preparedness and response efforts among border health authorities.
'This region faces a high risk of disease outbreaks due to dynamic cross-border movement,' said Josephine Vito Kaing, Environmental Health Officer and Epidemiologist, Ministry of Health, Tanzania. 'People travel daily for trade, work, education, religious activities, and even traditional healing, making coordinated preparedness and response essential.'
The Joint Cross-Border Committee, in line with the WHO International Health Regulations (IHR 2005), plays a pivotal role in coordinating health security efforts between Tanzania and Burundi. The committee consists of surveillance teams, border management authorities, and health officials from both nations, ensuring a harmonized approach to outbreak preparedness and response.
Diseases do not recognize borders, and a public health threat in one country can quickly escalate into a regional or even global crisis. 'A problem in Tanzania is a problem in Burundi and beyond. This is why cross-border committees must be formalized and fully operational to ensure coordinated prevention and response measures,'said Dr. Remedius Kakulu, Public Health Specialist and IHR Focal Point for Tanzania.
While some countries have strong Public Health Emergency Contingency Plans (PHECPs), disparities in preparedness, resources, and response capacity create challenges for coordination, he explained. To bridge these gaps, the cross-border committee plays a critical role in synchronizing disease surveillance efforts, improving information-sharing mechanisms, and harmonizing response measures to ensure a unified approach across borders.
The Cross-Border Committee, which includes national and regional health authorities, border management teams, and key stakeholders, is instrumental in aligning public health actions.
Dr. Mushi Benedict, Senior Knowledge Management and Public Health Specialist at ECSA-HC, highlighted a key challenge in implementing cross-border health security—unsynchronized funding. While some border areas receive financial support for vaccination campaigns and emergency preparedness, others lack the necessary resources, leading to inconsistencies in intervention efforts. He explained that although countries are willing to collaborate, the absence of harmonized funding mechanisms hampers long-term sustainability. Additionally, porous borders remain a major concern, as many travellers use unofficial routes, making disease detection and containment efforts even more difficult.
Dr. Nyandwi Stanislas, Technical Director of Preparedness, Response, and Resilience of Health Emergencies from Burundi, echoed similar concerns. 'While cross-border committees are in place, countries often struggle with inadequate human resources, both in terms of numbers and technical expertise,' he said. Border health officers lack proper training and equipment, making it difficult to implement effective surveillance and containment measures.
Despite efforts to establish structured border health interventions, limited financial resources prevent countries from scaling up their preparedness strategies. He called for greater investment in joint outbreak response planning and harmonized disease surveillance measures across the region.
The meeting resulted in several key agreements, including updating Public Health Emergency Contingency Plans, conducting tabletop simulations—discussion-based exercises where key personnel gather to evaluate their emergency response strategies—and enhancing joint disease surveillance through improved coordination.
Participants emphasized the need to integrate community-based surveillance mechanisms by engaging local leaders, traditional healers, and religious figures in health communication efforts. Training on the use of RING (Recognize, Isolate, Notify, Give) support cards for early identification of ill travelers was also highlighted as a critical area of focus.
Africa CDC, a key technical partner in the meeting, reaffirmed its commitment to supporting cross-border public health initiatives. Neema Kamara, Africa CDC's Field Coordinator for the MVD response in Kagera, emphasized that preparedness must be prioritized alongside response efforts.
'At Africa CDC, we recognize that responding to outbreaks is not enough—we must also invest in preparedness. Strengthening border public health information-sharing, synchronizing surveillance systems, and empowering local staff are key steps to ensuring we prevent future crises rather than just reacting to them,' she said.
The meeting concluded with a strong call to action directed at international partners, regional entities, and governments. Stakeholders urged the formalization and sustainable funding of cross-border health committees to ensure long-term coordination beyond donor-funded projects.
Key recommendations included integrating harmonized standard operating procedures across all border posts, expanding risk communication strategies in multiple languages, and prioritizing joint outbreak preparedness programs.
The outcomes of this meeting underscored a critical message—borders should not be barriers to health security. Countries must work together to strengthen regional health systems, synchronize disease response efforts, and ensure that no community is left vulnerable to the threat of emerging infectious diseases.
'When we collaborate, we learn from each other's successes and challenges. This is the only way we can build a stronger, more resilient health security framework for the region,' said Dr. Stanislas from Burundi.
With emerging health threats continuing to evolve, the need for sustained investment in cross-border public health security has never been greater. Africa must take bold steps to prioritize preparedness, harmonize surveillance strategies, and build resilient health systems—because no country is truly safe until its neighbors are safe as well.
Distributed by APO Group on behalf of Africa Centres for Disease Control and Prevention (Africa CDC).
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Economy ME
2 days ago
- Economy ME
MBRU scientists publish first Arab Pangenome Reference in major genomic breakthrough
Scientists at the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), the academic and research arm of Dubai Health , have achieved a major milestone in global genomic science with the publication of the first Arab Pangenome Reference. Featured in Nature Communications , a leading peer-reviewed journal, the study marks a pivotal advancement in precision medicine and personalized healthcare for Arab populations. The landmark achievement supports the UAE's National Genome Strategy, a 10-year initiative launched in 2023 by the Emirates Genome Council. The strategy aims to transform healthcare in the UAE through cutting-edge genomic research focused on personalized, preventive, and precision medicine. The Arab Pangenome Reference was created using high-quality DNA sequencing from 53 individuals of diverse Arab heritage residing in the UAE. Conducted at MBRU's state-of-the-art Center for Applied and Translational Genomics (CATG), the research identified more than 110 million base pairs of novel DNA sequences. Additionally, it uncovered nearly 9 million small genetic variations and over 235,000 large structural differences unique to Arab populations — none of which had been previously reported in global DNA references. Read: Sheikh Hamdan awards golden visas to nurses with 15+ years of service at Dubai Health Leadership insights Professor Alawi Alsheikh-Ali , director general, Dubai Health Authority (DHA), and co-author of the study, said: 'This achievement strengthens the UAE's position in genomic science. By building a reference that reflects the genetic diversity of Arab populations, we are enabling more precise and equitable healthcare. It's a foundational step towards realising the goals of our National Genome Strategy and ensuring that future medical innovations are shaped by data from our own communities.' Dr. Hanan Al Suwaidi, acting Provost of MBRU, and co-author of the study said: 'The capabilities of the CATG lab were central to the success of this project. From genetic sequencing to advanced bioinformatics, every stage of the research was completed in-house. This level of integration gave us full control over quality and timelines, reflecting Dubai Health's commitment to building world-class infrastructure and fostering national scientific leaders.' Dr. Mohammed Uddin, director of CATG and associate professor of Genetics at MBRU, and senior author of the study, said: 'This pangenome reference marks a major advancement in our understanding of Arab genomic diversity. It serves as a critical resource for both research discovery and clinical genome diagnostics, with lasting impact for future generations across the region.' Professor Alawi Alsheikh-Ali, director general, Dubai Health Authority (DHA) Addressing gaps in global genomic databases Historically, global genomic databases have significantly underrepresented Arab populations, limiting the accuracy of genetic risk assessment and treatment strategies for these communities. The Arab Pangenome Reference fills a critical gap by introducing high-resolution genomic data from a population long absent in international references. One particularly notable finding from the study was the discovery of the duplicated gene TAF11L5, which is highly enriched among Arab individuals but missing in existing global genomic references. Researchers believe this gene could influence the regulation of other genes and may hold important insights into disease risk and variations in treatment response. Enabling precision healthcare in the Arab World The Arab Pangenome Reference provides a foundational tool for national and regional precision medicine initiatives. It enables the development of population-specific biomarkers, disease risk models, and targeted therapies — advancing the region's ability to deliver more accurate, personalized healthcare solutions. Alongside the genomic map, the research team also introduced a new bioinformatics tool called PanScan. Designed to support more complex analysis of human pangenomes, PanScan helps researchers detect gene duplications, novel DNA variants, and complex genomic structures. Though not the main focus of the study, the tool has been made freely available on GitHub, offering global researchers access to further investigate human genomic diversity. The strategy aims to transform healthcare in the UAE through cutting-edge genomic research focused on personalized, preventive, and precision medicine A strategic step toward global representation Genomic research has progressed rapidly in recent decades, but much of the foundational data has come from a limited range of populations, creating blind spots in medical understanding. The Arab Pangenome Reference contributes to a growing international effort to correct this imbalance and promote global inclusivity in genomic science. The initiative also reflects Dubai Health's long-term commitment to research and innovation through MBRU. By investing in foundational studies such as this, Dubai Health is ensuring that Arab populations are actively represented in the future of genomics and precision healthcare. This groundbreaking research not only elevates the UAE's position in global genomic science but also lays the groundwork for more equitable, effective, and personalized healthcare systems across the Arab World.

Zawya
3 days ago
- Zawya
Jinja Hospital officials grilled over Shs1.2 billion payment of water bill
Officials from Jinja Regional Referral Hospital have been tasked to explain circumstances under which they paid Shs1.2 billion to clear water arrears despite being allocated only Shs68 million. The hospital officials led by the Director, Dr. Alfred Yayi appeared before the Public Accounts Committee (Central Government) chaired by the Vice Chairperson, Hon. Gorreth Namugga on Tuesday, 22 July 2025 to respond to queries in the Auditor General's report for the financial year 2023/2024. The legislators were concerned that clearing of the water bill with an amount more than had been allocated amounted to diversion or mischarge of funds. The committee members wondered if the hospital administration had sought authorization from the Ministry of Finance, Planning and Economic Development. 'We actually applaud your creativity in trying to save lives in Jinja City and beyond but we need transparency. Where exactly did you get the money? Which budget votes did you cut? If you used funds from the private wing, say so', Namugga said. According to the Auditor General's report, the hospital has accumulated water arrears of over Shs3.7 billion in a 10-year period. MPs questioned why the hospital had failed to prioritise settling such a substantial domestic arrear. 'So National Water and Sewerage Corporation is that lenient that you have been consuming water for over 10 years without payment? How did you manage that?' Namugga wondered. MPs were also dismayed with the continued under budgeting for utilities by the hospital administrators. 'It seems you are the ones creating these financial problems. You cannot expect government to give you more money when you are under-budgeting. If you need Shs90 million and only budget for Shs30 million, where do you expect the shortfall to come from?' asked Hon. David Karubanga (NRM, Kigorobya County). UPDF Representative, Hon. Victor Nekesa questioned how such a persistent issue continues unresolved even though the hospital submits its budget. Dr. Alfred Yayi requested for more time to provide a comprehensive explanation regarding the source of funds used to clear part of the water arrears after his initial explanation citing a USAID-funded project, was dismissed as insufficient. 'We have not fully addressed the specific issue raised. We request a few hours and will respond by the end of the day,' Dr. Yayi said. He added that while the hospital receives funds from government, it also benefits from a USAID initiative called G2G which reimburses funds upon meeting certain milestones. According to Dr. Yayi, these reimbursements can be used for hospital priorities. Distributed by APO Group on behalf of Parliament of the Republic of Uganda.


Khaleej Times
18-07-2025
- Khaleej Times
'We were heard': Father thanks Dubai Ruler for Dh7 million that saved child's life
In a calm and quite infusion room inside Dubai's Al Jalila Children's Hospital, two-and-a-half-year-old Yaqeen Ibrahim Kanaker giggles as her father gently plays with her. Around her, doctors and nurses move quietly, preparing the equipments required for the treatment. The atmosphere is calm, full of anticipation and hope. At 9.05am, doctors along with the nurses walked in carrying a small, sealed red box that contains the life-saving gene therapy medicine and could change Yaqeen's future forever. Looking at it, Yaqeen's mother stood frozen as she saw the medicine being brought in. Her eyes followed every movement. And then, she smiled, the kind of smile that only a mother who's lived through months of fear and sleepless nights could give. Her eyes rose up, but she didn't cry. Instead, she took a deep breath of relief, of hope, and of gratitude. 'Today, my daughter gets a second chance at life,' she said softly, almost as if trying to convince herself that this wasn't just another dream. A few weeks ago, this moment felt impossibly far. The family, Syrian nationals residing in the UAE, had launched an emotional plea on social media to save their daughter who was diagnosed with spinal muscular atrophy (SMA), a rare, serious, and life-threatening genetic disorder and the treatment costs Dh7 million. But then came a miracle — Sheikh Mohammed bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE and Ruler of Dubai, responded to their plea. His office reached out directly to the family and informed them that he would cover the full cost of the gene therapy, giving Yaqeen the lifeline she urgently needed. 'I still can't believe it,' said Ibrahim Kaneker, Yaqeen's father. 'When I got the call, I broke down. I didn't know what to say. I never imagined our cry for help would reach Sheikh Mohammed himself. May God bless him and give him abundantly, he saved our daughter's life.' 'She just stopped moving her legs' Yaqeen was six months old when her parents noticed something wasn't right. 'She had just started rolling over,' said her mother. 'But then, she stopped. She wasn't kicking her legs anymore. She was quiet. We thought maybe she was tired. But then the days went by... and nothing changed.' After multiple visits to the doctors and several rounds of testing, the family was given the heartbreaking diagnosis of spinal muscular atrophy, Type 2. It is a genetic condition that affects motor neurons in the spinal cord and brainstem, gradually weakening the muscles that control movement, breathing, and swallowing. 'We were shattered,' said Ibrahim. 'She was so small… how could she already have something so serious? As a father, you want to protect your child. But how do you protect her from something inside her own body?' Arrival of treatment Dr Haitham El Bashir, neuro-rehabilitation specialist and head of the gene therapy programme at Al Jalila Children's Hospital, oversaw Yaqeen's treatment. 'She has been diagnosed with SMA, and her symptoms began at around six months,' he said. 'We saw her a few weeks ago, ran all the necessary tests and screening, and confirmed she is eligible for gene therapy.' The therapy, which costs millions, is a one-time infusion that works by replacing the faulty gene responsible for SMA. 'Today is a big day for her,' said Dr El Bashir. 'The infusion will take about an hour, and then she will stay with us for 24 hours for observation. After that, she will visit us weekly for the next three months so we can monitor her progress. I am very optimistic. She is already showing signs of strength, and with this therapy, she'll have a real chance.' Yaqeen's mother did not speak much. She didn't need to and her expressions said it all. 'This moment, I will remember forever. When I saw the medicine being brought in… I can't describe the feeling. It was like the weight of the world was lifted from my chest. My daughter's smile tells me everything will be okay.' A nation that cares As the family shared their story, there was one emotion that was repeated again and again: gratitude. Gratitude to the UAE, to the hospital staff, to strangers who shared their posts and prayed for them. And most of all, to Sheikh Mohammed. 'He didn't know us. But he helped us like we were his own,' said Ibrahim. My daughter has a chance because we are here, because we were heard.'